We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Improved Expression of Recombinant Human Factor IX by Co-expression of GGCX, VKOR and Furin.
- Authors
Liu, Jianming; Jonebring, Anna; Hagström, Jonas; Nyström, Ann-Christin; Lövgren, Ann
- Abstract
Recombinant human FIX concentrates (rhFIX) are essential in the treatment and prevention of bleeding in the bleeding disorder haemophilia B. However, due to the complex nature of FIX production yields are low which leads to high treatment costs. Here we report the production of rhFIX with substantially higher yield by co-expressing human FIX with GGCX (γ-glutamyl carboxylase), VKOR (vitamin K epoxide reductase) and furin (paired basic amino acid cleaving enzyme) in Chinese hamster ovary (CHO) cells. Our results show that controlled co-expression of GGCX with FIX is critical to obtain high rhFIX titre, and, that co-expression of VKOR further increased the yield of active rhFIX. Furin co-expression improved processing of the leader peptide of rhFIX but had a minor effect on yield of active rhFIX. The optimal expression level of GGCX was surprisingly low and required unusual engineering of expression vector elements. For VKOR and furin the control of expression was less critical and could be achieved by standard vector element. Using our expression vectors an rhFIX-producing clone with an expression level of up to 30 mg/L of active rhFIX was obtained. In addition an efficient single step purification method was developed to obtain pure and active rhFIX with up to 94 % yield.
- Subjects
BLOOD coagulation factor IX; HEMOPHILIA; VITAMIN K epoxide reductase; FURIN protein; HAMSTERS; GENETIC vectors; PREVENTION
- Publication
Protein Journal, 2014, Vol 33, Issue 2, p174
- ISSN
1572-3887
- Publication type
Article
- DOI
10.1007/s10930-014-9550-5